Fluoride and Osteoporosis

Proceedings of the Society for Experimental Biology and Medicine

Volumn 191, Issue 3, 1989, Pages 278-286

  Pak, Charles Y C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORIDE;

BONE MASS; FRACTURE; GASTROINTESTINAL HEMORRHAGE; HUMAN; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE;

BIOMECHANICS; BONE AND BONES; FLUORIDES; HUMAN; OSTEOPOROSIS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024307739     PISSN: 00379727     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/00379727-191-42921     Document Type: Article

References (80)

1. Kanis JA, Meunier PJ. Should we use fluoride to treat osteoporosis?: A review. Q J Med 210:145-164, 1984.
2. Bikle DD. Fluoride treatment of osteoporosis: A new look at an old drug. Ann Intern Med 98:1013-1015, 1983.
3. Farley SMG, Wergedal JE, Smith LC, Lundy MW, Farley JR, Baylink DJ. Fluoride therapy for osteoporosis: Characterization of the skeletal response by serial measurements of serum alkaline phosphatase activity. Metabolism 36:211-218, 1987.
4. Leone NC, Stevenson CA, Hilbish TF, Sosman MC. A roentgenologic study of a human population exposed to high-fluoride domestic water. Am J Roentgenol 74:874-885, 1955.
5. Bernstein DS, Sadowsky N, Hegsted DM, Guri DC, Stare FJ. Prevalence of osteoporosis in high- and low-fluoride areas in North Dakota. JAMA 198:85-90, 1966.
6. Simonen O, Laitinen O. Does fluoridation of drinking water prevent bone fragility and osteoporosis? Lancet 2:432-434,1985.
7. Madans J, Kleinman JC, Cornoni-Huntley J. The relationship between hip fracture and water fluoridation: An analysis of national data. Public Health Briefs 73:296-298, 1983.
8. Sowers MFR, Wallace RB, Lemke JH. The relationship of bone mass and fracture history to fluoride and calcium intake: A study of three communities. Am J Clin Nutr 44:889-898, 1986.
9. Hodge HC, Smith FA. Fluoride. In: Bronner F, Coburn JW, Eds. Disorders of mineral metabolism. New York: Academic Press, Vol 1:pp 439-481, 1981.
10. Whitford GM, Pashley DH. Fluoride absorption: The influence of gastric acidity. Calcif Tissue Int 36:302-307, 1984.
11. Ekstrand J, Ehrnebo M. Influence of milk products on fluoride bioavailability in man. Eur J Clin Pharmacol 16:211-215, 1979.
12. Jowsey J, Riggs BL. Effect of concurrent calcium ingestion on intestinal absorption of fluoride. Metabolism 27:971-973, 1978.
13. Whitford GM, Williams JL. Fluoride absorption: Independence from plasma fluoride levels. Proc Soc Exp Biol Med 181:550-554, 1986.
14. Binswanger HS. Renal handling of fluoride in healthy man. Renal Physiol 5:192-196, 1982.
15. Ekstrand J, Ehmebo M, Boreus L. Fluoride bioavailability after intravenous and oral administration: Importance of renal clearance and urine flow. Clin Pharmacol Ther 23:329-337, 1978.
16. Ekstrand J, Dont LDS, Ehrnebo M. The relationship between plasma fluoride, urinary excretion rate and urine fluoride concentration in man. J Occup Med 25:745-748, 1983.
17. Ekstrand J, Ericsson Y, Rosell S. Absence of protein-bound fluoride from human blood plasma. Arch Oral Biol 22:229-232, 1977.
18. Ebifegha ME, Code RF, Harrison JE, McNeill KG, Szyjkowski M. In vivo analysis of bone fluoride content via NMR. Phys Med Biol 32:439-451, 1987.
19. van Kesteren RG, Duursma SA, Visser WJ, van der Sluys Veer J, Backer Dirks O. Fluoride in serum and bone during treatment of osteoporosis with sodium fluoride and vitamin D. Metab Bone Dis Rel Res 4:31-37, 1982.
20. Taves DR. New approach to the treatment of bone disease with fluoride. Fed Proc 29:1185-1187, 1970.
21. Singer L, Ophaug R. Ionic and nonionic fluoride in plasma (or serum). CRC Crit Rev Clin Lab Sci 18:111-140, 1982.
22. Harrison JE, McNeill KG, Sturtridge WC, et al. Three-year changes in bone mineral mass of postmenopausal osteoporotic patients based on neutron activation analysis of the central third of the skeleton. J Clin Endocrinol Metab 52:751-758, 1981.
23. Pak CYC, Sakhaee K, Gallagher C, et al. Attainment of therapeutic fluoride levels in serum without major side effects using a slow release preparation of sodium fluoride in postmenopausal osteoporosis. J Bone Min Res 1:563-571, 1986.
24. Ekstrand J, Alvan G, Boreus LO, Norlin A. Pharmacokinetics of fluoride in man after single and multiple oral doses. Eur J Clin Pharmacol 12:311-317, 1977.
25. Eanes ED, Reddi AH. The effect of fluoride on bone mineral apatite. Metab Bone Dis Rel Res 2:3-10, 1979.
26. Larsen MJ, Thorsen A. A comparison of some effects of fluoride on apatite formation in vitro and in vivo. Calcif Tissue Int 36:690-696, 1984.
27. Grynpas MD, Simmons ED, Pritzker KPH, Hancock RV, Harrison JE. Is fluoridated bone different from non-fluoridated bone? In: Ali SY, ed. Cell Mediated Calcification and Matrix Vesicles. Amsterdam: Elsevier, pp 409-414, 1986.
28. Christoffersen J, Christoffersen MR. The effect of bendroflume- thiazide and hydrochlorothiazide on the rate of dissolution of calcium hydroxyapatite. Calcif Tissue Int 36:431-434, 1984.
29. Spencer H, Kramer L, Wiatrowski E, Lender M. Fluoride therapy in metabolic bone disease. Isr J Med Sci 20:373-380, 1984.
30. Manzke E, Rawley R, Vose G, Roginsky M, Rader JI, Baylink DJ. Effect of fluoride therapy on nondialyzable urinary hydroxyproline, serum alkaline phosphatase, parathyroid hormone, and 25-hydroxy vitamin D. Metabolism 26:1005-1010, 1977.
31. Farley JR, Wergedal JE, Baylink DJ. Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone-forming cells. Science 222:330-332, 1983.
32. Farley JR, Tarbaux NM, Lau KHW, Baylink DJ. Monofluorophosphate is hydrolyzed by alkaline phosphatase and mimics the actions of NaF on skeletal tissues, in vitro. Calif Tissue Int 40:35-42, 1987.
33. 3+ plus F on the catecholamine-stimulated GTPase activity of purified and reconstituted G. Biochemistry 25:7036-7041, 1986.
34. 2-mediated stimulation of cyclic AMP formation in isolated bone cells. Calcif Tissue Int 36:279-284, 1984.
35. Susheela AK, Singh M. Adenyl cyclase activity following fluoride ingestion. Toxicol Lett 10:209-212, 1982.
36. Anderson RE, Kemp JW, Jee WSS, Woodbury DM. Effects of cortisol and fluoride on ion-transporting ATPase activities in cultured osteoblastlike cells. In Vitro 20:847-855, 1984.
37. Zerwekh JE, Morris AC, Padalino PK, Gottschalk F, Pak CYC. Fluoride and parathyroid hormone raises intracellular calcium in human osteoblasts. J Bone Min Res (in press).
38. Lau KHW, Farley JR, Baylink DJ. Molecular mechanism of mitogenic action of fluoride (F) on osteoblasts (OB). Am Soc Bone Min Res 2:232, 1987.
39. Sharma YD. Effect of sodium fluoride on collagen cross-link precursors. Toxicol Lett 10:97-100, 1982.
40. Susheela AK, Jha M. Effects of fluoride on glycosaminoglycan of cancellous and cortical bone of rabbits. Experientia 37:1097-1099, 1981.
41. Sharma YD. Variations in the metabolism and maturation of collagen after fluoride ingestion. Biochim Biophys Acta 715:137-141, 1982.
42. Susheela AK, Jha M. Cellular and histochemical characteristics of osteoid formed in experimental fluoride poisoning. Toxicol Lett 16:35-40, 1983.
43. Eastell R, Riggs BL. Treatment of osteoporosis. Obstet Gynecol Clin North Am 14:77-88, 1987.
44. Baylink DJ, Bernstein DS. The effects of fluoride therapy on metabolic bone disease. Clin Orthop Rel Res 55:51-85, 1967.
45. Kanis JA. Treatment of osteoporotic fracture. Lancet 2:27-33, 1984.
46. Jowsey J, Schenk RK, Reutter FW. Some results of the effect of fluoride on bone tissue in osteoporosis. J Clin Endocrinol Metab 28:869-874, 1968.
47. Compston JE, Chadha S, Merrett AL. Osteomalacia developing during treatment of osteoporosis with sodium fluoride and vitamin D. Br Med J 281:910, 1980.
48. Meunier PJ, Galus K, Briancon D, et al. Treatment of primary osteoporosis with drugs that increase bone formation: Sodium fluoride, hPTH 1-34, ADFR concept. In: Christiansen C, Arnaud CD, Nordin BEC, Parfitt AM, Peck WA, Riggs BL, Eds. Osteoporosis, International Symposium on Osteoporosis. Department of Clinical Chemistry Oylosbrun Hospital, Copenhagen, Denmark, pp 595-602, 1984.
49. 2 on trabecular bone balance and remodeling in osteoporotics. Bone 6:381-389, 1985.
50. Olah AJ, Reutter RW, Dambacher MA. Effects of combined therapy with sodium fluoride and high doses of vitamin D in osteoporosis. A histomorphometric study in the iliac crest. In: Courvoisier B, Donath A, Eds. Fluoride and Bone. Bern: Hans Huber, p 242, 1978.
51. Lundy MW, Wergedal JE, Teubner E, Burnell J, Baylink DJ. The effect of prolonged fluoride therapy for osteoporosis: Bone composition and histology. 34th Annual Meeting, Orthopaedic Research Society, February 1-4, 1988, Atlanta, Georgia.
52. Zerwekh JE, Sakhaee K, Johnson KD, Pak CYC. Histomorphometric evaluation if intermittent fluoride therapy in post-menopausal osteoporosis. 34th Annual Meeting, Orthopaedic Research Society, February 1-4, 1988, Atlanta, Georgia.
53. Raymakers JA, Van Dijke CF, Hoekstra A, Duursma SA. Monitoring fluoride therapy in osteoporosis by dual photon absorptiometry. Bone 8:143-148, 1987.
54. Hansson T, Roos B. The effect of fluoride and calcium on spinal bone mineral content: A controlled, prospective (3 years) study. Calcif Tissue Int 40:315-317, 1987.
55. Duursma SA, Glerum JH, Van Dihk A, Bosch R, Kerkhoff H, Van Putten J, Raymakers JA. Responders and non-responders after fluoride therapy in osteoporosis. Bone 8:131-136, 1987.
56. Juhn A, Healey JH, Schneider R, Lane JM, Bansal M. Reversal of femoral and vertebral osteoporotic bone loss. 34th Annual Meeting, Orthopaedic Research Society, February 1-4, 1988, Atlanta, Georgia.
57. Farley SM, Libanati CL, Odvina CV, et al. Long-term fluoride and calcium therapy acts to correct the deficit of spinal bone density in osteoporosis. Submitted for publication.
58. Dambacher MA, Ittner J, Ruegsegger P. Long-term therapy of postmenopausal osteoporosis. Bone 7:199-205, 1986.
59. Christiansen C, Christensen MS, McNair P, Hagen C, Stocklund K-E, Transbol IB. Prevention of early postmenopausal bone loss: Controlled 2-year study in 315 normal females. Eur J Clin Invest 10:273-279, 1980.
60. Franke J, Rempel JH, Franke M. Three years' experience with sodium-fluoride therapy of osteoporosis. Acta Orthop Scand 45:1-20, 1974.
61. Rosen D, Gedalia I, Anaise J, Simkin A, Arcan M. The effect of fluoride alone or fluoride followed by calcium and vitamin D on disuse osteoporosis of the rat tail vertebrae. Calcif Tissue Res 19:9-15, 1975.
62. Beary DF. The effects of fluoride and low calcium on the physical properties of the rat femur. Anat Rec 164:305-316, 1969.
63. Riggins RS, Zeman F, Moon D. The effects of sodium fluoride on bone breaking strength. Calcif Tissue Res 14:283-289, 1974.
64. Riggs BL, Seeman E, Hodgson SF, Taves DR, O'Fallon WM. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. N Engl J Med 306:446-450, 1982.
65. Lane JM, Healey JH, Schwartz E, et al. Treatment of osteoporosis with sodium fluoride and calcium: Effects on vertebral fracture incidence and bone histomorphometry. Orthop Clin North Am 15:729-745, 1984.
66. Power GRI, Gay JDL. Sodium fluoride in the treatment of osteoporosis. Clin Invest Med 9:41-43, 1986.
67. Kuntz DK, Marie P, Naveau B, Maziere B, Tubiana M, Ryckewaert A. Extended treatment of primary osteoporosis by sodium fluoride combined with 25 hydroxycholecalciferol. Clin Rheum 3:145-153, 1984.
68. Hasling C, Nielsen HE, Melsen F, Mosekilde L. Safety of osteoporosis treatment with sodium fluoride, calcium phosphate and vitamin D. Min Elect Mefab 13:96-103, 1987.
69. Briancon D, Meunier PJ. Treatment of osteoporosis with fluoride, calcium, and vitamin D. Orthop Clin North Am 12:629-648, 1981.
70. Lie H, Malde K, Sortenberg K, Hasvold O, Ekren T, Malm OJ. Long-term fluoride and calcium therapy of postmenopausal osteoporosis. J Oslo City Hosp 32:147-154, 1982.
71. O'Duffy JD, Wahner HW, O'Fallon WM, et al. Mechanism of acute lower extremity pain syndrome in fluoride-treated osteoporotic patients. Am J Med 80:561-566, 1986.
72. Schnitzler M, Solomon L. Histomorphometric analysis of a calcaneal stress fracture: A possible complication of fluoride therapy for osteoporosis. Bone 7:193-198, 1986.
73. Gutteridge DH, Price RI, Nicholson GC, et al. Fluoride in osteoporotic vertebral fractures—trabecular increase, vertebral protection, femoral fractures. Copenhagen International Symposium on Osteoporosis, June 3-8, 1984, Aalborg Stiftsbogtryk-keri.
74. Riggs BL, Baylink DJ, Kjeerekoper M, Lane JM, Melton LJ III, Meunier PJ. Incidence of hip fractures in osteoporotic women treated with sodium fluoride. J Bone Min Res 2:123-126, 1987.
75. Posen GA, Marier JR, Jaworski ZI. Renal osteodystrophy in patients on long-term hemodialysis with fluoridated water. Fluoride 4:114-128, 1971.
76. Gerster JC, Charhon SA, Jaeger P, et al. Bilateral fractures of femoral neck in patients with moderate renal failure receiving fluoride for spinal osteoporosis. Br Med J 287:723-725, 1983.
77. Hahn TJ, Halstead LR, Teitelbaum SL. Altered mineral metabolism in glucocorticoid-induced osteopeni. Effect of 25-hydroxyvitamin D administration. J Clin Invest 64:655-665, 1979.
78. Rejou F, Dumas R, Belon C, Meunier PJ, Edouard E. Fluoride treatment in corticosteroid induced osteoporosis. Arch Dis Child 61:1230-1231, 1986.
79. Harrison JE, Hitchman AJW, Hasany SA, Hitchman A, Tam CS. The effect of fluoride on nephrolcalcinosis in rats. Clin Biochem 18:109-113, 1985.
80. Pak CYC, Sakhaee K, Zerwekh, Parcel C, Peterson R, Johnson K. A safe and effective treatment of primary osteoporosis by intermittent application of slow-release sodium fluoride: Augmentation of vertebral bone mass and inhibition of fractures. J Clin Endocrinol Metab 68:150-159, 1989.